We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
-1.88%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$3.73B
AUM Growth
-$641M
Cap. Flow
-$442M
Cap. Flow %
-11.83%
Top 10 Hldgs %
5.17%
Holding
1,489
New
168
Increased
277
Reduced
362
Closed
84

Top Sells

Rank Stock Value
1
LHX icon
L3Harris
LHX
+$18.8M
2
WAT icon
Waters Corp
WAT
+$15.6M
3
CMI icon
Cummins
CMI
+$15.3M
4
CI icon
Cigna
CI
+$15.1M
5
AMP icon
Ameriprise Financial
AMP
+$13.2M

Sector Composition

Rank Sector Weight
1 Financials 27.38%
2 Energy 11.53%
3 Industrials 10.56%
4 Consumer Discretionary 10.28%
5 Technology 9.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LODE icon
1276
Comstock
LODE
$245M
$96K ﹤0.01%
22,900
SHPW
1277
DELISTED
Shapeways Holdings, Inc. Common Stock
SHPW
$96K ﹤0.01%
19,161
OCC icon
1278
Optical Cable Corp
OCC
$143M
$95K ﹤0.01%
27,600
PTN
1279
Palatin Technologies
PTN
$13.8M
$95K ﹤0.01%
322
-224
-41% -$74.1K
XELB icon
1280
Xcel Brands
XELB
$6.6M
$95K ﹤0.01%
9,920
ZDGE icon
1281
Zedge
ZDGE
$38.9M
$95K ﹤0.01%
40,380
SER icon
1282
Serina Therapeutics
SER
$36M
$95K ﹤0.01%
4,827
OTIC
1283
DELISTED
Otonomy, Inc.
OTIC
$95K ﹤0.01%
323,500
AWX icon
1284
Avalon Holdings
AWX
$10.1M
$94K ﹤0.01%
35,500
HYPD
1285
Hyperion DeFi Inc
HYPD
$40.9M
$94K ﹤0.01%
599
RFL icon
1286
Rafael Holdings
RFL
$107M
$93K ﹤0.01%
52,379
UAVS icon
1287
AgEagle Aerial Systems
UAVS
$53.9M
$93K ﹤0.01%
200
ALIM
1288
DELISTED
Alimera Sciences
ALIM
$93K ﹤0.01%
18,300
EMBK
1289
DELISTED
Embark Technology, Inc. Common Stock
EMBK
$93K ﹤0.01%
+12,500
New +$124K
MRKR icon
1290
Marker Therapeutics
MRKR
$18.7M
$92K ﹤0.01%
24,922
VERO
1291
DELISTED
Venus Concept
VERO
$92K ﹤0.01%
1,265
FUSB icon
1292
First US Bancshares
FUSB
$91.1M
$91K ﹤0.01%
11,468
CRVO icon
1293
CervoMed
CRVO
$26.6M
$89K ﹤0.01%
11,043
VHC icon
1294
VirnetX Holding Corp
VHC
$63.1M
$89K ﹤0.01%
3,815
MTEM
1295
DELISTED
Molecular Templates, Inc.
MTEM
$89K ﹤0.01%
7,913
CDTX
1296
DELISTED
Cidara Therapeutics
CDTX
$88K ﹤0.01%
7,000
-5,000
-42% -$69K
SRGA
1297
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$88K ﹤0.01%
25,156
AIM
1298
AIM ImmunoTech
AIM
$7.91M
$88K ﹤0.01%
1,512
ALGS icon
1299
Aligos Therapeutics
ALGS
$34.6M
$87K ﹤0.01%
3,160
+880
+39% +$29.2K
CBIO
1300
Crescent Biopharma
CBIO
$626M
$86K ﹤0.01%
1,554

Similar funds

Bridgeway Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Bridgeway Capital Management held 1,489 positions worth $3.73B, down 15% from $4.38B the previous quarter. Its ten largest holdings account for 5.2% of the portfolio.

Bridgeway Capital Management withdrew a net $442M in Q3 2022, closing 84 positions and reducing 362 holdings. Its most notable exit was L3Harris, an estimated $18.8M position sold in full.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 27% a quarter earlier, followed by Energy and Industrials.

Against the trend, Bridgeway Capital Management opened a new position in Cleveland-Cliffs worth $11M.

  • Bridgeway Capital Management's largest Q3 2022 buy was Cleveland-Cliffs: 819,000 shares worth $11M.
  • Bridgeway Capital Management added most to Meta Platforms (Facebook) in Q3 2022, an estimated $13.9M increase.
  • Bridgeway Capital Management's biggest Q3 2022 reduction was Waters Corp, cutting an estimated $15.6M.
  • Bridgeway Capital Management fully exited L3Harris in Q3 2022, selling an estimated $18.8M.
  • Bridgeway Capital Management's ten largest holdings make up 5.2% of its $3.73B portfolio in Q3 2022.
  • Bridgeway Capital Management opened 168 new positions and closed 84 in Q3 2022.
  • Bridgeway Capital Management's portfolio value fell 15% quarter-over-quarter to $3.73B.

Based on Bridgeway Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.